A Phase 1 Study of Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Multiple Metastases
This phase I trial studies the side effects and the best dose of stereotactic body radiation
therapy in treating patients with breast cancer, non-small cell lung cancer, or prostate
cancer that has spread to other parts of the body. Stereotactic body radiation therapy
delivers fewer, tightly-focused, high doses of radiation therapy to all known sites of
cancer in the body while minimizing radiation exposure of surrounding normal tissue.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society